I
IMMUNOVANT INC
NASDAQ: IMVT (Immunovant, Inc.)
Last update: 4 hours ago33.61
0.17 (0.51%)
| Previous Close | 33.44 |
| Open | 33.21 |
| Volume | 1,105,431 |
| Avg. Volume (3M) | 1,844,746 |
| Market Cap | 6,900,432,896 |
| Price / Book | 8.09 |
| 52 Weeks Range | |
| Earnings Date | 10 Aug 2026 |
| Diluted EPS (TTM) | -2.73 |
| Total Debt/Equity (MRQ) | 0.01% |
| Current Ratio (MRQ) | 11.16 |
| Operating Cash Flow (TTM) | -375.87 M |
| Levered Free Cash Flow (TTM) | -227.82 M |
| Return on Assets (TTM) | -37.97% |
| Return on Equity (TTM) | -62.46% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Immunovant, Inc. | Bullish | Bearish |
AIStockmoo Score
2.0
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 2.00 |
|
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn). |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 58.17% |
| % Held by Institutions | 55.78% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Deep Track Capital, Lp | 31 Mar 2026 | 11,526,971 |
| Baker Bros. Advisors Lp | 31 Mar 2026 | 5,457,881 |
| Tcg Crossover Management, Llc | 31 Mar 2026 | 4,457,988 |
| Two Seas Capital Lp | 31 Mar 2026 | 3,201,962 |
| Jennison Associates Llc | 31 Mar 2026 | 3,196,705 |
| Rtw Investments, Lp | 31 Mar 2026 | 3,177,849 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |